Description
Tesamorelin — Advanced Research Peptide for Fat Reduction & Neuroregeneration
Tesamorelin is a synthetic 44–amino acid peptide and a stable analogue of growth hormone–releasing hormone (GHRH). Originally developed for HIV-associated lipodystrophy, it has also shown promise in studies exploring nerve regeneration, cognitive health, and significant visceral fat reduction. Engineered with high purity, Tesamorelin remains one of the most widely studied research peptides in the field of metabolic and neurological health.
What is Tesamorelin?
Tesamorelin is a modified version of natural GHRH, enhanced with a trans-3-hexanoic acid group for improved stability and potency. It received FDA approval in 2010 for treating HIV-related lipodystrophy, and ongoing studies continue to explore its applications in nerve damage recovery and early cognitive decline.
How Tesamorelin Works
Tesamorelin stimulates the pituitary gland to release growth hormone in a natural, pulse-like rhythm. This mechanism helps in:
Research Applications
Reducing deep abdominal (visceral) fat Supporting lipid metabolism and cholesterol balance Enhancing peripheral nerve repair Potentially improving cognitive function
Key Benefits Observed in Research
Visceral Fat Reduction — Clinical trials show Tesamorelin can reduce abdominal fat by up to 20%, making it one of the most effective peptides in this area. Cardiovascular Health — Helps lower triglycerides, cholesterol, and inflammation by reducing ectopic fat in the liver and around the heart. Growth Hormone Deficiency Support — Safely restores GH levels in individuals showing deficiency markers. Nerve Regeneration Potential — Studied for its role in repairing peripheral nerve damage from diabetes or surgical injury. Cognitive Function — Early data suggests Tesamorelin may improve brain chemistry markers tied to mild cognitive impairment.
Peptide Profile
Peptide Type: GHRH Analogue Sequence: 44 amino acids Molecular Weight: 5195.9 g/mol CAS Number: 901758-09-6 PubChem CID: 44147413
Research & Usage
Tesamorelin continues to be widely studied in research fields such as:
HIV-associated lipodystrophy and metabolic disorders Cardiovascular health and fat metabolism Peripheral nerve injury and regeneration Cognitive decline and neurodegenerative conditions
For Research Use Only — Not for Human or Animal Consumption